Silverwood, S., Asaro, A., Shahi, P., Suliman, E., Musa, M. S., Weygand, J.
, Tanderup, K., Lichter, K. E. & Bhatia, R. K. (2025).
Less Is More: Hypofractionation for Equitable and Sustainable Cancer Care.
JCO Global Oncology,
11, e2500153.
https://doi.org/10.1200/GO-25-00153
Bahlis, N. J., Zonder, J., Karlin, L., Plesner, T., Paris, L., Wrobel, T., Hungria, V., Besemer, B., Crusoe, E.
, Silkjaer, T., Perrot, A., Moreau, P., Wu, K. L., Delimpasi, S., Dimopoulos, M. A., Levin, M. D., Mangiacavalli, S., Nnane, I., Kim, Y. J. ... Facon, T. (2025).
Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study.
Leukemia and Lymphoma,
66(14), 2685-2696.
https://doi.org/10.1080/10428194.2025.2561117